Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$2.83 - $5.11 $72,102 - $130,192
25,478 New
25,478 $128,000
Q2 2021

Aug 13, 2021

SELL
$25.45 - $37.64 $172,805 - $255,575
-6,790 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$29.16 - $51.96 $197,996 - $352,808
6,790 New
6,790 $205,000
Q3 2020

Nov 13, 2020

SELL
$35.13 - $43.62 $278,686 - $346,037
-7,933 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$23.66 - $49.53 $187,694 - $392,921
7,933 New
7,933 $343,000

Others Institutions Holding YMAB

About Y-mAbs Therapeutics, Inc.


  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $356M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.